1. Johannesburg, 13 th August 2009 Outstanding Business Action to Stop TB: How Companies Contribute to the Global Fight 2009 TB Case Studies Shuma Panse Global Business Coalition on HIV/AIDS, TB and Malaria (New York office)

2. GBC Case Studies 2 GBC Case Studies: Inspire readers with unique programs and innovative leveraging of core competencies Motivate by documenting concrete and measurable program outcomes Provide action-oriented guidance and critical success factors Grouped by industry or intervention type for target audiences GBC identifies, collects, synthesizes and disseminates best practices in private sector engagement on HIV, TB and malaria

3. Case Study Collections 3 Current Publications GBC Awards for Business Excellence (Annual Winner Profiles) Travel & Tourism: Guidebook and Case Studies In Good Company: How Business Fights the Feminization of HIV/AIDS Outstanding Business Action to Stop TB: How Companies Contribute to the Global Fight Coming Soon: Malaria Case Studies Publication (in partnership with the World Economic Forum)

4. 4 Ease of access - Over 100 in-depth case studies available online - Customize filters by disease, region, industry, or intervention type - Search by company or keyword Additional online resources -Supplemental materials include IEC materials, program indicators and outcomes and more - Click through to member company profiles or “related topics” Online Case Studies

5. Companies’ Response to Engagement in activities around tuberculosis TB information and education Strategies to prevent transmission in workplace &/or community Integration of TB &HIV activities Treatment regimen in line with NTP and Int'l Standards (DOT) Early identification of TB suspects and prompt diagnosis Only 40% of companies surveyed offer TB information and education in the workplace (n=83) Why TB Case Studies?

6. 6 Outstanding Business Action to Stop TB: Who, What & Why Every industry has a role to play in tackling TB! Featured Companies Eli Lilly Chevron Corporation AstraZeneca Ogilvy Healthworld BD AngloGold Ashanti Bayer Healthcare Barrick Gold Corporation Industry Pharma Oil & Gas Pharma PR Medical Mining Pharma Mining

7. Four Action Areas WorkplaceCommunityCore Competence Advocacy Eli Lilly XX Chevron XXX AstraZeneca XX Ogilvy Healthworld XX BD XX Anglogold Ashanti X Bayer Healthcare X Barrick Gold XX

8. Though the type of intervention, scale and outcome of each program may vary, all of them share the following elements: Corporate commitment to stopping TB Initial focus on risk assessment Integrated approach to disease management Partnerships with TB stakeholders Diverse Programs With Shared Elements

9. Each case study includes: 9 BUSINESS OVERVIEW PROGRAM DESCRIPTION CRITICAL SUCCESS FACTORS

10. Advocacy Profile: Health Communications & Marketing Competencies Message Mapping for HIV & TB

11. R&D Profile: Assess the use of moxifloxacin in the treatment of TB Partnership with the TB Alliance for Drug Development

12. GBC TB Tools & Resources 2009 TB Case Studies Issue Briefs M&E CD-ROM

13. Together, we can Stop TB Photo Credit: James Nachtwey (www.XDRTB.org)